Stem cells are vital for regenerating and repairing the organs such as the heart, lungs, skin, germ cells and other tissues. But the characteristics of normal stem cells and the discovery of origin of leukemia have headed the scientist to the hypothesis that cancer may initiate from stem cell-like cells. Cancer stem cells are now thought to be responsible for cancer initiation, progression, metastasis, recurrence and drug resistance. There are some similarities and differences between CSCs and healthy stem cells in signaling pathways (Wnt/ β-catenin, Hh, Notch), epigenetic modifications, telomere maintenance, and degree of dependence on the stem cell niche, maintenance of multipotency and self-renewability of respective progenitor cells. Distinct and specific surface biomarker phenotypes can be used to distinguish CSC from other tumor cells and normal stem cells through single and combination of markers such as CD44, CD34 + CD38 × and CD133. Recently, miRNAs have been tried as a marker and therapeutic agents against cancers stem cell such as miR-34a, miR-199a, miR-181, miR-125b-2 and miR-128. However, targeting CSCs without harming their normal counterparts is an advantageous way in the design of novel therapies but many questions remain unknown.
Introduction
Stem cell research is one of the most fascinating areas of contemporary biology because SCs have the potency to regenerate and repair the organs such as the heart, lungs, skin, germ cells and other tissues. In the 3-to 5-day-old blastocyst, the inner cells differentiated and developed to the entire body and organs ( Hongbao and Ma, 2014) . Given their exclusive regenerative aptitudes, SCs offer new potentials for treating diseases such as diabetes, primary immune deficiencies, aplastic anemia, severe haemoglobinopathies, cartilage and bone disorders, neurological diseases, skin and skinappendage disorders and heart disease (Strulovici et al., 2007) . By definition, SCs are necessarily undifferentiated cells of a multicellular organism that have the ability to proliferate themselves, going through the self-renewal and to produce mature cells of a particular tissue type (same and other) under highly controlled microenvironment. So far, SC self-renewability is maintained by two mechanisms namely obligatory asymmetric replication and stochastic differentiation (Morrison and Kimble, 2006) . However, the features of SCs and the discovery of the link of leukemia (AML) initiation with CSCs have changed the way of thinking about the origin of cancer that cancer may initiate and contain self-renewal stem cell-like cells (Han et al., 2013; Logtenberg and Boonstra, 2013) . The CSCs of leukemic blasts in AML initiated from antecedent cells in the bone marrow (Dickson et al., 2014) . Surprisingly, AML mutated cells are found to be highly resistant to chemotherapy and are responsible for the recurrence of AML after an initial complete retardation, even after chemotherapy they rapidly replenish the leukemic cell population (Yu et al., 2012) .So, AML-CSCs are those specific types of cells which initiate, progress cancer and somehow sustain in cell populations. Phenotypically, the cells (SC and CSC) in subpopulation look the same under the microscope but express a unique combination of surface molecules (Logtenberg and Boonstra, 2013; Tang, 2012) . Cancer stem cells have self-renewal properties but with defectively regulated niche that lead to differentiate and create tumor, can metastasize eventually to remote site. Moreover, CSCs are able to avoid immune system and resistant against chemotherapy (Sengupta and Cancelas, 2010; Zhou et al., 2009; Zhou et al., 2014) .
Understanding the role of different pathways, epigenetic regulations and niche condition for initiation of progenitor cancer stem cell and identification of CSCs within cancer cell population is essential for the development of anticancer therapy, because diverse populations of cancer cells inside a tumor can switch back and forth between one cell that divide quickly but do not attack, and stem cell-like cells split deliberately but are extremely metastatic (Kantara et al., 2014) . The intention of this review is to focus on the differences and similarities between stem cells andcancer stem cells, role of stem cell niches and epigenetic regulation and finally we discuss the current research on CSCs molecular markers and strategies for CSCs therapy, in brief.
Cancer Stem Cells and Stem Cells
Cancer stem cells have been defined as a small subpopulation of cancer cells within cancer microenvironment and niche that establish a reservoir of self-sustaining cells with the exclusive ability to self-renew and to form the heterogeneous lineages of cancer cells that comprise the tumor (Logtenberg and Boonstra, 2013) .
It could also be defined as likely all SSCs, CSCs are unspecialized (they have no unique tissue-specific structures), they can divide and renew themselves for long periods and they can give rise to specialized cells. They can therefore recapitulate tumor heterogeneity as they can be found in tumors. However, increasing evidence has showed that there are more similarities between CSCs and normal SCs (Reya et al., 2001; Shackleton, 2010) . One of the prominent similarity between healthy stem cells and CSCs behavior is of EMT that via an alteration from a polarized epithelial cell type to a nonpolarized mesenchymal cell type, CSCs are derived with SCs properties including migratory, self-renewal and differentiation properties (Eridani, 2014; Martin-Belmonte and Perez-Moreno, 2011) . One of the differences between normal stem cells and cancer stem cells is their degree of dependence on the stem cell niche, a specialized microenvironment in which stem cells reside.
Cancer stem cells may involve deregulation or alteration of the niche by dominant proliferation-promoting signals whereas normal SC has support and been supported by niche which provides homeostasis maintenance (Li, 2006 (Shay and Wright, 2010) . Based on the frequency of occurrence, healthy stem cells are present in the tissues in a very small amount but CSCs can be a rather large population in the bulk of tumor cells (Jaworska et al., 2015) . In addition to their ability to self-renew and Interestingly, in serum free media, sometimes CSC can differentiate into progenitor cells (House et al., 2015) . A.Common features found in normal and cancer stem cells (Bapat et al., 2010) 01 Capacity for asymmetric divisions (self-renewal) thatproduces a quiescent stem cell and a dedicated progenitor and plays important role toward emerging a dangerous cell mass.
02
Regulation of self-renewability by similar signaling pathways (Wnt, Sonic Hedgehog, MAPK and Notch) and at the epigenetic level by BMI-1.
03
Capacity to arrange a hierarchy of cellular derivatives that includes progenitors and differentiating cells.
04
Extended telomeres and telomerase activity that increases the cellular life span.
05
Predilection for growth factor independence through secretion of growth factors and cytokines.
06
Stimulation of angiogenesis through secretion of angiopoietic factors.
07
Expression of similar surface receptors (e.g., CXCR4, CD133, a6 integrin, c-kit, c-met, LIF-R) those are either identified as stem cell markers or are associated with homing and metastases.
B. Normal stem cell properties versus CSC properties (Topcul et al., 2013) 
Theories of the Origin of Cancer Stem Cell
A single cancer cell has the ability to give rise to fresh cancer and engender heterogeneous progeny which provides proof for a stem-cell origin of cancer (Ghaffari, 2011) . In the first probability, if a normal SC develops into CSC that indicates that it has already got a full stem-cell package notably differentiated into several progenitor cells, properties (Takahashi et al., 2007) . Table 2 summaries the possible theories of the origin of cancer stem cell. (Sell, 2010) 01 Transformation of stem cells existing in a tissue, resulting in transformed growth and differentiation properties.
02 Transformation of a native pool of early precursors that reacquire self-renewal properties.
03 Sequence of effective mutations which render devoted transient-amplifying antecedent or differentiated somatic cells among a tissue immortal (de-differentiation).
04 Amalgamation of circulating bone-marrow derived stem cells with tissue-residing cells.
Tumor stem cell theory supported the GoldieColdman hypothesis and has the ability to explain how patients with metastatic disease display clinical deterioration after several months of starting treatment (Martin, 2013 (Yoo and Hatfield, 2008) .
In this view, cancer cells that are not stem cells cannot sustain against drug over the long term. However, in order for a cell to become cancerous, it must undergo a significant number of critical alterations in the DNA sequences that control the cell (Mayer et al., 2015 (Atsumi et al., 2008; He et al., 2009; Vermeulen et al., 2010) . In Brain CSCs the niche regulated the angiogenesis (Li, 2006) . Leukemic CSCs mice cell found to be competed with HSCs for their normal osteoblastic and vascular niches in culture (Pattabiraman and Weinberg, 2014) . As a result, normal
HSCs experience lack of support and reducing in number (Colmone et al., 2008) . Tumor-associated monocytes and macrophages reported as a CSC niche component which functioned through juxtacrine signaling. Interaction of CSCs and CAFs in their niche found to maintain basal cell or squamous cell carcinoma in culture. In some malignant melanoma, keratinocytes also contribute as microenvironmental factor (Lacina et al., 2015) . Many studies reported that Glioma stem cells (GSCs) reside in particular niches to maintain their behavior (Chen et al., 2015; Lathia et al., 2015) . A hypoxic microenvironment has been reported to be important in regulating GSC molecular and phenotypic features through the recruitment of vascular and stromal cells (Persano et al., 2013) . Thus, the microenvironment seems to be crucial for (Chen et al., 2013) . Type I CD44 cell-surface ligand is a useful marker for identifying CSCs in breast CSCs (Fillmore and Kuperwasser, 2007) . The expression of CD24 is a trademark of an extensive range of epithelial cancers and metastasis which is also used as a marker for CSC.
Marker CD133 was identified for breast CSCs but now used for several solid tumors (Visvader and Lindeman, 2012) . A marker, PROCR, identified using gene expression profiling of primary BCs, is also a marker of hematopoietic and ESCs (Zhang et al., 2014) .In metastasis stage, CXCR4 and ABCG2 could be used as CSC marker in BCs population (Bao et al., 2013) .
Oxidizing enzyme ALDH1 showed to be increased in CSCs and used to differentiate CSCs from different cancers sample (Ricardo et al., 2011) . Dual wavelength (Suetsugu et al., 2010) . Table 3 shows cancers stem marker (B) and their distribution (A). Table 3 . (A) Cancer stem cell types, (B) Identification stem cell marker, and (C) Combined chemotherapy and anti-CSC therapeutic strategies (Hu and Fu, 2012; Vidal et al., 2013) . 
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